We are live on ! Find out more
MDVN

MEDIVATION, INC.
MDVN

Delisted

MDVN was delisted on the 27th of September, 2016.

357 hedge funds and large institutions have $6.33B invested in MEDIVATION, INC. in 2015 Q3 according to their latest regulatory filings, with 54 funds opening new positions, 143 increasing their positions, 110 reducing their positions, and 67 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more funds holding in top 10

Funds holding in top 10: 47 (+3)

63% more call options, than puts

Call options by funds: $89.8M | Put options by funds: $54.9M

30% more repeat investments, than reductions

Existing positions increased: 143 | Existing positions reduced: 110

4% less funds holding

Funds holding: 373357 (-16)

19% less first-time investments, than exits

New positions opened: 54 | Existing positions closed: 67

26% less capital invested

Capital invested by funds: $8.56B → $6.33B (-$2.23B)

Holders
357
Holders Change
-16
Holders Change %
-4.29%
% of All Funds
9.96%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.2%
New
54
Increased
143
Reduced
110
Closed
67
Calls
$89.8M
Puts
$54.9M
Net Calls
+$34.8M
Net Calls Change
-$61.1M
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$963M -$42.6M -860,705 -4%
Vanguard Group
2
Vanguard Group
Pennsylvania
$464M +$15M +302,013 +3%
Wells Fargo
3
Wells Fargo
California
$212M -$73.3M -1,479,121 -23%
KCM
4
Knoll Capital Management
Florida
$187M
BIT
5
BlackRock Institutional Trust
California
$166M +$3.25M +65,654 +2%
DCM
6
Discovery Capital Management
Connecticut
$160M +$134M +2,700,600 +252%
BFA
7
BlackRock Fund Advisors
California
$159M +$13.4M +271,423 +8%
Adage Capital Partners
8
Adage Capital Partners
Massachusetts
$158M +$31.5M +635,000 +21%
JHIU
9
Janus Henderson Investors US
Colorado
$152M -$1.81M -36,573 -1%
William Blair Investment Management
10
William Blair Investment Management
Illinois
$136M +$158M +3,195,191 New
State Street
11
State Street
Massachusetts
$135M +$14.2M +285,998 +10%
First Trust Advisors
12
First Trust Advisors
Illinois
$110M -$37.5M -757,374 -23%
BB
13
BB Biotech
Switzerland
$110M
AQR Capital Management
14
AQR Capital Management
Connecticut
$105M +$22.8M +459,287 +23%
Deutsche Bank
15
Deutsche Bank
Germany
$98.8M -$14.1M -284,846 -11%
TCM
16
TimesSquare Capital Management
New York
$95.2M +$57.4M +1,157,800 +107%
Franklin Resources
17
Franklin Resources
California
$94.5M -$72.2M -1,457,540 -40%
Invesco
18
Invesco
Georgia
$87.7M -$36M -726,567 -26%
D.E. Shaw & Co
19
D.E. Shaw & Co
New York
$82.5M +$24M +485,484 +33%
HM
20
HealthCor Management
New York
$80.8M +$24.8M +500,000 +36%
RG
21
Redmile Group
California
$74.5M +$86.8M +1,752,642 New
WRF
22
Waddell & Reed Financial
Kansas
$71.5M -$18.8M -380,118 -18%
Point72 Asset Management
23
Point72 Asset Management
Connecticut
$69.8M +$71.5M +1,443,934 +731%
O
24
OppenheimerFunds
New York
$64.1M -$7.85M -158,480 -10%
UBS AM
25
UBS AM
Illinois
$63.2M -$1.29M -25,973 -2%

MDVN Hedge Fund Activity: Q3 2015 in Review

357 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in MEDIVATION, INC. (MDVN) for Q3 2015, worth a combined $6.33B — down 26% from $8.56B a quarter earlier.

Sellers outnumbered buyers: 67 funds closed out of MDVN and 54 opened new positions — a net loss of 13 holders — while 110 trimmed existing stakes and 143 added.

The largest buyer was Discovery Capital Management, adding an estimated $134M. The largest seller was OrbiMed, exiting entirely with an estimated $161M sold.

  • 357 institutional investors held MEDIVATION, INC. (MDVN) as of Q3 2015, down from 373 in Q2 2015.
  • Funds reported $6.33B of MEDIVATION, INC. stock for Q3 2015, down 26% quarter-over-quarter.
  • 54 funds opened new MEDIVATION, INC. positions in Q3 2015 and 67 closed out, a net change of -13 holders.
  • The largest MEDIVATION, INC. buyer in Q3 2015 was Discovery Capital Management, an estimated $134M added.
  • The largest MEDIVATION, INC. seller in Q3 2015 was OrbiMed, an estimated $161M sold.

Based on aggregated 13F filings for Q3 2015.